Pharmaceutical Cleanroom News
Get the latest pharmaceutical cleanroom news and updates below. Cleanroom Connect brings you the latest news from around the world, featuring current topics and news in the Pharmaceutical and Biotech industries.
Regulation and standards for “clean plants” have been increasing in recent years as China’s pharmaceutical R&D and production industry develops rapidly. EP & Clean Tech China 2019, hosted by CCCMHPI, UBM EMEA and UBM Sinoexpo, is an annual event of the pharma clean industry, that will blow a strong, new pharma clean wind in Hall N4 of Shanghai New International Expo Centre (SNIEC). Over 100 Chinese and overseas quality clean enterprises will gather on-site, to showcase the latest pharma cleanroom equipment and products, engineering technologies, and solutions, etc.
Seedo Corp and SYS Technologies Enter MOU to Cooperate in Development of Next-Generation Clean Growing Systems for Commercial Use
The Next Generation Greenhouse: AGT Unveils Cleanroom Technology, Energy Efficiency and Fast Build Times to Empower Growers
Sleek, modern structures full of patent-pending technologies such as Natural Earth Air System, oil bath fans and variable daylight control ushers in a new era for greenhouses
QuantumClean & ChemTrace will demonstrate how its ultra-high purity chamber tool part cleaning, proprietary coatings and microcontamination analytical testing can help reduce wafer fabrication Cost-of-Ownership (CoO). Solutions’ information is available during show hours at SEMICON Europa at the Messe München Exhibition Center in Munich, Germany from November 13 — 16, 2018 (booth A4510).
The scientists envision that such transient engineered technologies one day could complement or replace pharmaceutical treatments for a variety of medical conditions in humans. This type of technology, which the researchers refer to as a “bioresorbable electronic medicine,” provides therapy and treatment over a clinically relevant period of time and directly at the site where it’s needed, thereby reducing side effects or risks associated with conventional, permanent implants.
Lindström India launched its second line of business, called Cleanroom services in India to ensure the highest quality hygiene, safety and reliability which is most critical to customers in the pharmaceutical, food and electronics industry. Lindström’s cleanroom service ensures hygienic production facilities by providing garments serviced in cleanroom laundries which prevent contaminations during process hereby ensuring complete safety of the products being manufactured.
The Controlled Environmental Solutions business is made up of highly specialized testing and certification services, control procedures and tailored decontamination technology for the clean room to ensure optimal performance of the environment and end-user compliance to highly regulated industry standards.
A next-generation biomanufacturing plant incorporates multiple innovative technologies into a single facility, and therefore is built in half the construction time with approximately one half of the operating cost of a traditional plant. The next-generation biomanufacturing plant require a smaller manufacturing footprint and offer greater environmental benefits, including reduced consumption of water and energy and lower levels of carbon emissions.
The U.S. Food and Drug Administration (FDA) has approved the first ever non-surgical treatment for the rare neuroendocrine cancers pheochromocytoma and paraganglioma. The approval was based on a multi-center trial led by researchers in the Abramson Cancer Center of the University of Pennsylvania and was granted to Progenics Pharmaceuticals for AZEDRA.
Platelet BioGenesis (PBG), the leader in the production of functional human platelets (PLTs+™) from stem cells and the development of platelet-based therapeutics, announced it has moved into brand new lab space in Cambridge, MA. Located next to MIT, the newly renovated property puts Platelet BioGenesis in the heart of the most dynamic biotech cluster in the world.
The study demonstrates that the new plant system for norovirus vaccine production is effective against the tenacious pathogen and that the versatile method could be used for the development of a broad range of novel vaccines. It is estimated that an effective vaccine against gastroenteritis could save billions of dollars in healthcare costs in the U.S. alone.
Osteoarthritis (OA) is a joint disorder that affects 28 million people in the United States. With no current disease-modifying therapy for OA, most patients rely on symptomatic relief to manage joint inflammation and chronic pain.
Pharmaceutical Cleanroom News and Advancements
The Pharmaceutical Cleanroom Industry or medicine industry is the commercial industry that discovers, develops, produces, and markets drugs or pharmaceuticals for various uses and formations of medicines and medications. The pharmaceutical cleanroom industry produces the controlled aseptic cleanroom environments where by the pharmaceutical products are created and packaged. Pharmaceutical companies create a various array of products for different applications.
The primary developments of Pharmaceutical companies are generic medications, branded pharmaceuticals and medical devices. The pharmaceutical companies are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs. Cleanroom Connect provides the latest Pharmaceutical Cleanroom News from various pharmaceutical and biopharma industries. Subscribe today to receive pharmaceutical and biopharmaceutical news and updates directly to your mailbox.
The Pharmaceutical Cleanroom Industry is a booming industry, and production has been growing exponentially over the past few decades as innovations in the medical field have taken off. This increasing production has also led to increasing demands for safety features installed in industrial pharmaceutical manufacturing plants and storage areas. These safety procedures ensure the health of employees as well as the safe preservation of products that are stored for later use by consumers.